Corteva Finds Its Edge After U.S. Appeals Court Decision

Bayer's weed killer was taken off the market last week, diluting the competition

Digital Content Manager
Jul 23, 2020 at 10:26 AM
    facebook twitter linkedin


    Corteva Inc (NYSE:CTVA) on Wednesday was granted approval by the U.S. appeals court to continue selling its agricultural weed killer Enlist Duo, which environmentalists deemed detrimental to plants and wildlife. This decision comes one month after competitor Bayer's herbicide was blocked by the same court, giving Corteva a competitive edge in sales in the $40 billion U.S. soybean market. At last check, CTVA is slightly lower, trading down 0.4% at $28.55. 

    While CTVA looks to be cooling off today, the equity has found several layers of support on the charts in recent months. Specifically, the 80-day moving average captured several pullbacks in late June and early July, while the ascending 40-day sits directly below as potential support going forward. Today, CTVA is also testing support at its year-over-year breakeven level.

    The consensus among analysts is split, with nine in coverage calling CTVA a "buy" or better, while "10 say "hold" or worse. Meanwhile, the 12- month consensus target price of $31.18 is a 9.7% premium to current levels. 

    Options players, however, are definitely optimistic over Corteva stock. In the last 10 weeks, 9.38 calls were picked up for every put at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio sits lower than just 2% of readings from the past year, suggesting a healthier appetite for long calls than usual. 

     

     

     

     

    If you are not making money with options, you aren’t buying options like this…

    There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

     


     


     
    Special Offers from Schaeffer's Trading Partners